CBX4 promotes antitumor immunity by suppressing Pdcd1 expression in T cells

Area of Science:

• Immunology
• Epigenetics
• Oncology

Background:

• CBX4 (chromobox 4) is a component of Polycomb Repressive Complex 1 (PRC1) involved in gene regulation.
• Its role in T-cell-mediated antitumor immunity is not well understood.
• Tumor growth, metastasis, and angiogenesis are known to be regulated by CBX4.

Purpose of the Study:

• To investigate the function of CBX4 in T-cell-mediated antitumor immunity.
• To elucidate the molecular mechanisms by which CBX4 influences T-cell function and PD-1 expression.

Main Methods:

• Generation of mice with T-cell-specific deletion of Cbx4.
• Analysis of tumor growth and tumor-infiltrating lymphocytes (TILs).
• Assessment of cytokine production (TNF-α, IFN-γ) and PD-1 levels in T cells.
• Epigenetic analysis of the Pdcd1 promoter, including histone modifications (H2AK119ub1, H3K27me3).
• Investigation of the effects of PRC1 and PRC2 inhibition on Pdcd1 expression.

Main Results:

• T-cell-specific Cbx4 deletion accelerated tumor growth.
• Knockout mice exhibited impaired TNF-α and IFN-γ production in TILs and elevated PD-1 levels.
• Dysregulated Pdcd1 expression and impaired T-cell receptor (TCR) stimulation response were observed in peripheral T cells.
• CBX4 overexpression downregulated Pdcd1 expression.
• Cbx4 deficiency reduced inhibitory histone modifications at the Pdcd1 promoter.
• Inhibition of PRC1 or PRC2 restored Pdcd1 expression in Cbx4-transfected cells.

Conclusions:

• CBX4 plays a crucial role in regulating T-cell function and antitumor immunity.
• CBX4 epigenetically controls Pdcd1 expression through histone modifications at its promoter.
• This study reveals a novel mechanism linking CBX4, epigenetic regulation, and T-cell immune surveillance.